BIRC5 and cancer: Compound 1 showed an important inhibition of the NF-κB pathway and a moderate ability to downregulate the survivin level, while compound 3 behaved as a strong antiproliferative agent in both 2D and 3D cancer cell cultures, a cell migration inhibitor, and a potent survivin downregulator.